Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Conversant Bio logo — Providing researchers worldwide with high-quality, timely, a...

Conversant Bio

Providing researchers worldwide with high-quality, timely, and budget-friendly tissue samples for in-depth disease investigation.

Founded 2006 4 employees Grant Total: $50.00K Biopharma, Biotechnology

General Information

Company Name Conversant Bio
Founded Year 2006
Employees 4
Industries Biopharma, Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Conversant Bio. To contact Conversant Bio, visit conversantbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Conversant Bio compare?

A PDF of Conversant Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Conversant Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Conversant Bio

Conversant Bio is a biotech startup founded in 2006, dedicated to providing researchers worldwide with high-quality, timely, and budget-friendly tissue samples for in-depth disease investigation. The company's slogan, "Providing researchers worldwide with high-quality, timely, and budget-friendly tissue samples for in-depth disease investigation," reflects its commitment to supporting advanced investigations into severe diseases. With a vast network of over 50 U.S.-based clinical sites and an IRB-reviewed Quality Control System for chain of custody, Conversant Bio ensures the delivery of the highest quality samples on time and within budget. The startup received a $50.00K grant investment on 24 March 2015. With a focus on the biopharma and biotechnology industries, Conversant Bio holds a promising position in the field of tissue sample supply for disease research.

Business keywords: biomedical research, tissue samples, disease investigation, clinical research network, quality control system, research collaboration

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $50.00K -
24 Mar 2015

Conversant Bio Alternatives & Competitors

View All Alternatives
Conversant Bio vs
Aurion Biotech
Aurion Biotech United States

We're on a mission to cure blindness with our transformational platform of advanced therapies

Acquired
94 employees
Biopharma, Biotechnology
Conversant Bio vs
Maybio Matrix
Maybio Matrix

Advancing the future of maxillofacial tissue regeneration with innovative biological scaffold soluti...

Series A
Biopharma, Biotechnology
Conversant Bio vs
Pleno Inc.
Pleno Inc. United States

Targeted biological information at unprecedented scale, precision and performance.

Series B
39 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Conversant Bio

Providing researchers worldwide with high-quality, timely, and budget-friendly tissue samples for in-depth disease investigation.
Conversant Bio was founded in 2006.
Conversant Bio operates in Biopharma and Biotechnology. Its work centres on biomedical research, tissue samples, disease investigation and clinical research network.
Conversant Bio has approximately 4 employees.
Conversant Bio has completed 1 funding round, raising a total of $50.00K. The latest funding stage is Grant.
Top alternatives and competitors to Conversant Bio include Aurion Biotech, Maybio Matrix, Pleno Inc., BIOTECK S.P.A., FuturNet Communication. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Conversant Bio and Aurion Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Conversant Bio, https://bouncewatch.com/company/conversant-bio, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes